Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,026 public trials 1,169 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

NCT02628067

Conditions: Adenocarcinoma, Adenoma, Advanced Cancer, +88 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

NCT06205706

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
Locations: Rigshospitalet Copenhagen, Denmark

Universitätsklinikum Essen Essen, Germany

Hospital HM Nou Delfos Barcelona, Spain

HM Sanchinarro Madrid, Spain

View Trial Details

Active, Not Recruiting

Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study

NCT06917560

Conditions: Adenocarcinoma, Autoantibody, Carcinoma, +16 more
Locations: first hospital affiliated of Fujian medical university Fuzhou, Fujian, China

View Trial Details

Active, Not Recruiting

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

NCT03647163

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation

NCT04163289

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: London Regional Cancer Program of the Lawson Health Research Institute London, Ontario, Canada

View Trial Details

Active, Not Recruiting

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

NCT05653882

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations: City of Hope Duarte, California, United States

UCLA Los Angeles, California, United States

UCSD San Diego, California, United States

UCSF San Francisco, California, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03937219

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Exelixis Clinical Site #116 La Jolla, California, United States

Exelixis Clinical Site #166 Orange, California, United States

Exelixis Clinical Site #29 Boca Raton, Florida, United States

Exelixis Clinical Site #44 Miami, Florida, United States

View all 159 locations

View Trial Details

Active, Not Recruiting

Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

NCT02978118

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Active, Not Recruiting

Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

NCT04669496

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
Locations: Zhongshan hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, Not Recruiting

A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma

NCT04047251

Conditions: Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations: HonorHealth Scottsdale, Arizona, United States

Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Dana Farber Cancer Institute (DFCI) Boston, Massachusetts, United States

Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions